Related Experiment Video
Updated: Jul 18, 2026

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
Published on: April 2, 2013
The compromised host and Legionnaires' disease
Abstract:
Pneumonia caused by Legionnaires' disease bacterium was recognized in eight patients during a 7-month period. The patients were immunosuppressed by their underlying illness, corticosteroid therapy, and other exogenous immunosuppressive agents. Five of the patients had received immunosuppressive therapy for less than 16 days. Clinical presentation was similar to that of other bacterial pneumonias in compromised patients. Legionnaires' disease progressed to necrotizing pneumonia with abscess formation and respiratory failure in two patients. Diagnosis was made by [1] culture of lung tissue and bronchial washings; [2] direct fluorescent antibody staining of lung tissue, sputum, and bronchial washings; and [3] serologic evidence of infection. Therapy with oral erythromycin was ineffective. Intravenous erythromycin was given to six patients, with a good response. However, two patients showed further clinical improvement after rifampin was added. Because this illness may be more severe in compromised hosts, open lung biopsy and special microbiologic tests should be done when Legionnaires' disease is suspected.
Insights
Legionnaires' disease in immunosuppressed patients can be severe, leading to necrotizing pneumonia. Intravenous erythromycin showed good response, with rifampin aiding further improvement in some cases.
Area of Science:
- Infectious Diseases
- Pulmonology
- Immunology
Background:
- Legionnaires' disease bacterium can cause severe pneumonia, particularly in immunocompromised individuals.
- Immunosuppression in patients was linked to underlying illnesses, corticosteroid therapy, and other immunosuppressive agents.
Purpose of the Study:
- To describe the clinical presentation, diagnosis, and treatment outcomes of Legionnaires' disease in immunosuppressed patients.
Main Methods:
- Diagnosis involved culture of lung tissue and bronchial washings, direct fluorescent antibody staining, and serologic testing.
- Treatment efficacy was assessed for oral and intravenous erythromycin, with and without rifampin.
Main Results:
- Eight immunosuppressed patients were diagnosed with Legionnaires' disease over seven months.
- Clinical presentation mimicked other bacterial pneumonias in compromised hosts.
- Two patients developed necrotizing pneumonia with abscess formation and respiratory failure.
- Oral erythromycin was ineffective; intravenous erythromycin yielded good responses in six patients.
- Two patients improved further with the addition of rifampin.
Conclusions:
- Legionnaires' disease can be severe in immunocompromised hosts.
- Prompt diagnosis via open lung biopsy and specialized microbiologic tests is crucial.
- Intravenous erythromycin is a viable treatment, and rifampin may offer additional benefit.
More Related Videos
Related Concept Videos
Stages of Infection
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Bacterial Phylum Spirochaetes
Reservoir of Infection
Colonisation of Pathogens
Atypical Pneumonia

